Andrews Julie
Director · Officer · RXST, OFIX
As of 2026-09-16, Andrews Julie has 12 Form 4 transactions on record across 2 companies — 7 in the trailing 12 months.
Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.
Pattern in the record: open-market sales filed in January in multiple years since 2025 — a recurring calendar cadence, more consistent with scheduled activity than a one-off decision.
Reconstructed holdings
Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.
Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.
Trades by company
Filing ledger
| Date | Company | Action | Shares @ price | Value | Ownership Δ | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| 2026-03-05 | OFIX | Sale | 2,363 @ $12.55 | $30K | −2.6% of holding | 88,746 | Form 4 |
| 2026-03-04 | OFIX | Sale | 2,425 @ $12.92 | $31K | −2.6% of holding | 91,109 | Form 4 |
| 2026-01-16 | OFIX | Sale | 4,873 @ $14.38 | $70K | −7.7% of holding | 58,039 | Form 4 |
| 2025-01-16 | OFIX | Sale | 4,655 @ $17.89 | $83K | −14.1% of holding | 28,312 | Form 4 |
8 award / exercise / gift records — not counted as purchases
| Date | Company | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|
| 2026-06-17 | RXST | Award / grant | 37,037 | 78,076 | Form 4 |
| 2026-06-17 | RXST | Award / grant | 37,037 | 78,076 | Form 4 |
| 2026-03-03 | OFIX | Award / grant | 35,495 | 93,534 | Form 4 |
| 2026-03-03 | OFIX | Award / grant | 84,261 | 84,261 | Form 4 |
| 2025-06-03 | RXST | Award / grant | 10,752 | 41,039 | Form 4 |
| 2025-06-03 | RXST | Award / grant | 10,752 | 41,039 | Form 4 |
| 2025-03-03 | OFIX | Award / grant | 34,600 | 62,912 | Form 4 |
| 2025-03-03 | OFIX | Award / grant | 82,070 | 82,070 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.